1,370.00p
-0.15%
Close of 9 Nov 2026, in pence
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About CVS Group
Its shares trade on LSE under the ticker CVSG.L. It has been listed since 10 October 2007. In the fiscal year to 30 June 2026, it reported revenue of £712.8m and net income of £17.3m. At that date it held total assets of £767.8m and shareholders' equity of £290.1m.
CVS Group Plc is a holding company, which engages in the provision of veterinary services. The company is headquartered in Diss, Norfolk. The company went IPO on 2007-10-10. The principal activities of the Company are to operate animal veterinary practices, veterinary diagnostic businesses, pet crematoria and an online pharmacy and retail business. Its segments are Veterinary Practice, Laboratories, Pet Crematoria and Animed Direct. The Veterinary Practice segment offers treatment for companion animals, equine and farm animals. The Laboratories segment provides diagnostic services to its veterinary practices and third-parties. Its laboratories provide Biochemistry, hematology, histology, serology and advanced allergy testing. The Pet Crematoria segment offers pet cremation services to its veterinary practices, third-party practices and directly to pet owners. The Animed Direct segment sells prescription and non-prescription drugs, pet food and other animal related products through its Website. The company operates approximately 360 veterinary practices, four diagnostic laboratories, seven pet crematoria and an online dispensary.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Providers & Services
- Listed since
- 10 Oct 2007
- Employees
- 6,548
- Website
- cvsukltd.co.uk ↗
Leadership
Pay as last reported
- Mr. David WiltonNon-Executive Independent Chairman of the Board£155,000
- Mr. Richard FairmanChief Executive Officer, Executive Director, since 2018£721,000
- Mr. Robin AlfonsoChief Financial Officer, Executive Director, since 2018£494,000
- Mr. Claire SlaterChief Operating Officer
- Mr. Paul HiggsChief Veterinary Officer, Executive Director, since 2024£393,000
- Mr. Scott MorrisonCompany Secretary
- Mr. Richard GrayNon-Executive Independent Director£54,000
- Ms. Deborah KempSenior Non-Executive Independent Director£57,000
- Ms. Joanne ShawNon-Executive Independent Director£56,000
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 68
- Environment
- 99
- Social
- 67
- Governance
- 39
- Direct emissions (scope 1)
- 9,947 t
- Energy emissions (scope 2)
- 2,877 t
- Value chain emissions (scope 3)
- 606 t
- Women in the workforce
- 87%
- Carbon reduction policy
- Yes
- Human rights policy
- Yes
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Diverse Portfolio: CVS Group has a comprehensive range of veterinary services, including companion animal, equine, and farm animals.
- Strong Market Presence: The company is one of the leading providers of veterinary services in the UK, enjoying a significant market share.
- Experienced and Professional Staff: CVS Group is supported by a team of highly skilled veterinarians and specialists, ensuring quality care for animals.
Weaknesses
- Limited International Presence: CVS Group's operations are primarily focused in the UK, potentially limiting opportunities for global expansion.
- Reliance on External Suppliers: The company heavily depends on suppliers for pharmaceuticals, equipment, and other veterinary products, which may pose challenges in terms of cost and availability.
- Vulnerability to Economic Fluctuations: Economic downturns or other financial crises could impact pet owners' willingness to spend on veterinary services, potentially affecting CVS Group's profitability.
Opportunities
- Increasing Pet Ownership: The rising trend of pet ownership offers significant growth opportunities for CVS Group as more owners seek veterinary care for their companion animals.
- Technological Advancements: Embracing emerging technologies in diagnostics, treatments, and operational efficiency can enhance CVS Group's services and drive competitive advantage.
- Acquisition and Expansion: CVS Group can explore strategic acquisitions or expansion into new territories to increase market share and diversify its service offerings.
Threats
- Intense Competition: The veterinary industry is highly competitive, with numerous small and large players, which may put pressure on CVS Group's market position and pricing.
- Regulatory Changes: Changes in government regulations and compliance requirements can impact the operations and cost structure of CVS Group.
- Public Health Outbreaks: Outbreaks of zoonotic diseases or public health concerns can potentially disrupt veterinary services and impact client demand.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.